CorVel - CRVL Stock Forecast, Price & News

CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.

Analyst Upgrades and Downgrades

Separately, TheStreet upgraded CorVel from a "c+" rating to a "b" rating in a research report on Friday, July 15th.

CorVel Stock Performance

Shares of CRVL Stock traded up $1.48 during mid-day trading on Monday, hitting $158.94. 53,473 shares of the stock traded hands, compared to its average volume of 42,346. The firm has a market cap of $2.79 billion, a price-to-earnings ratio of 43.31 and a beta of 0.95. The company's 50-day simple moving average is $149.44 and its 200-day simple moving average is $158.18. CorVel has a twelve month low of $129.19 and a twelve month high of $213.38.

CorVel (NASDAQ:CRVL - Get Rating) last issued its earnings results on Tuesday, August 2nd. The business services provider reported $0.94 earnings per share (EPS) for the quarter. The business had revenue of $176.31 million for the quarter. CorVel had a return on equity of 30.93% and a net margin of 9.89%.

Insider Buying and Selling

In related news, CFO Brandon O'brien sold 1,204 shares of CorVel stock in a transaction on Tuesday, June 14th. The stock was sold at an average price of $134.01, for a total value of $161,348.04. Following the transaction, the chief financial officer now directly owns 2,664 shares in the company, valued at approximately $357,002.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Brandon O'brien sold 1,204 shares of CorVel stock in a transaction on Tuesday, June 14th. The stock was sold at an average price of $134.01, for a total transaction of $161,348.04. Following the transaction, the chief financial officer now owns 2,664 shares in the company, valued at $357,002.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman V Gordon Clemons sold 1,000 shares of CorVel stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $165.59, for a total value of $165,590.00. Following the transaction, the chairman now owns 454,920 shares in the company, valued at approximately $75,330,202.80. The disclosure for this sale can be found here. Insiders have sold 69,906 shares of company stock worth $10,727,417 in the last three months. 48.56% of the stock is currently owned by insiders.